FOXP3 and ovarian carcinoma: Conversely, FoxP3+ regulator T cells (Tregs), through their immunomodulatory role, have been correlated with therapeutic resistance and worse survival outcomes in many solid tumors, although their role in ovarian cancer is still not completely defined.5, 7, 8, 9